Skip to main content

Biolinerx Ltd ADR(BLRX-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

BioLineRx Reports Second Quarter 2023 Financial Results and Recent Corporate and Portfolio Updates

PR Newswire - Wed Aug 30, 2023

- On Track for September 9, 2023 PDUFA Target Action Date on NDA for Motixafortide in Stem Cell Mobilization (SCM) for Autologous Transplantation in Multiple Myeloma (MM) -

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe